.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
subscribe to breaking news emails
.
.
the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men.
.
.
.
.
.
.
.